Executive Director, Artificial Intelligence / Machine Learning Partnerships, Eli Lilly
Gregg’s role at Lilly focuses on how we can best collaborate with a wide range of partners to combine our resources and expertise to advance the next generation of AI/ML models and tools to help improve drug discovery. Gregg was part of the founding team behind Lilly TuneLab — a collaborative platform created to offer biotechs access to AI/ML tools leveraging Lilly’s own drug discovery models, and then to continuously improve these models via federated learning across data sourced from the ecosystem of TuneLab member companies. Prior to Lilly, Gregg spent over 10 years operating in cross-functional teams delivering impactful ML/AI powered solutions across drug discovery, biotech, digital health, and tech; at varying scales from startups up to Apple iOS feature releases.